SPECIAL NOTICE
65 -- Proleukin 22ML
- Notice Date
- 3/24/2025 10:17:43 AM
- Notice Type
- Special Notice
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- 262-NETWORK CONTRACT OFFICE 22 (36C262) Gilbert AZ 85297 USA
- ZIP Code
- 85297
- Solicitation Number
- 36C26225Q0695
- Response Due
- 3/31/2025 10:00:00 AM
- Archive Date
- 04/30/2025
- Point of Contact
- Hestia Sim, Contract Specialist
- E-Mail Address
-
Hestia.Sim@va.gov
(Hestia.Sim@va.gov)
- Awardee
- null
- Description
- Special Notice Page 3 of 3 NOTICE OF INTENT TO SOLE SOURCE This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The Department of Veterans Affairs, Network Contracting Office (NCO) 22, located at 4811 Airport Plaza Drive, Long Beach, CA is issuing this Notice of Intent (NOI) to inform industry contractors of the Government s intent to execute a Sole Source Delivery Order under FAR Part 8, specifically FAR Part 8.405-6(a)(1)(B), Only One Available Source. The North American Industry Classification System (NAICS) for this requirement is 325412, Pharmaceutical Preparation Manufacturing. The Federal Supply Class (FSC) is 6505, Drugs and Biologicals. The Small Business Administration (SBA) size standard for this sector is 1,300 Employees. The intended contractor is Iovance Biotherapeutics Manufacturing, LLC located at 300 Rouose Blvd, Philadelphia, PA 19112. Place of Performance is the VA San Diego Healthcare System located at 3350 La Jolla Village Drive, San Diego, CA 92161. VA San Diego Pharmacy Service intends to purchase Proleukin 22ML in quantities listed below: NDC# Contract Description Qty UOM 76310-0022-01 36F79724D0206 PROLEUKIN 22MILLION UNT/VIL INJ 54 EA VA San Diego Pharmacy requires the Proleukin 22ML for direct patient care. This mandatory contract for the Proleukin 22ML was awarded to Iovance Biotherapeutics Manufacturing, LLC on 9/6/2024 under contract 36F79724D0206 with the period of performance of 9/6/2024 9/30/2029. This notice of intent is neither a formal solicitation nor a request for competitive proposals. No solicitation document is available and telephone requests will not be honored. No award will be made on the basis of unsolicited quotations or offers received in response to this notice. Any response to this notice must show clear and compelling evidence that the responding company can provide the same items/services, and that competition will be advantageous to the Government. The intent of this synopsis is for informational purposes only. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this action based on this notice is solely within the discretion of the Government. All inquiries and concerns must be addressed in writing via e-mail to Hestia Sim, Hestia.Sim@va.gov with RESPONSE TO INTENT TO SOLE SOURCE VISN 22 Proleukin 22ML in the subject line. All interested parties who are responsible, certified, and capable may identify their interest and may submit a capabilities statement no later than 10:00 AM Pacific Local Time March 31, 2025, to the above-mentioned point of contact. The interested parties bear full responsibility to ensure complete transmission and timely receipt. The Department of Veterans Affairs will NOT be responsible for any costs incurred by interested parties in responding to this notice of intent.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/17b9d7213ee345738c78508ce5ee6dc1/view)
- Record
- SN07382685-F 20250326/250324230040 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |